TTR and hereditary amyloidosis: It is important to note that lipid-encapsulated nanoparticles containing small interfering double-stranded RNA (siRNA) have been employed to target transthyretin (TTR) mRNA, leading to the degradation of TTR deposits in patients with TTR-mediated hereditary amyloidosis [9].